Page last updated: 2024-08-16

piracetam and carfilzomib

piracetam has been researched along with carfilzomib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bhattacharyya, S; Cai, X; Klein, JP; LaBuzetta, JN; Munshi, NC; Plitt, A; Raibagkar, P; Schleicher, SM	1

Other Studies

1 other study(ies) available for piracetam and carfilzomib

Article	Year
Management of Posterior Reversible Encephalopathy Syndrome Induced by Carfilzomib in a Patient With Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016, Jan-10, Volume: 34, Issue:2 Topics: Anticonvulsants; Antihypertensive Agents; Antineoplastic Agents; Biomarkers, Tumor; Bortezomib; Brain; Disease Management; Disease Progression; Female; Humans; Immunoglobulin kappa-Chains; Levetiracetam; Magnetic Resonance Imaging; Middle Aged; Multiple Myeloma; Neurologic Examination; Nimodipine; Nootropic Agents; Oligopeptides; Piracetam; Polyneuropathies; Posterior Leukoencephalopathy Syndrome; Secondary Prevention; Seizures	2016

Article

Year

Management of Posterior Reversible Encephalopathy Syndrome Induced by Carfilzomib in a Patient With Multiple Myeloma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016, Jan-10, Volume: 34, Issue:2

Topics: Anticonvulsants; Antihypertensive Agents; Antineoplastic Agents; Biomarkers, Tumor; Bortezomib; Brain; Disease Management; Disease Progression; Female; Humans; Immunoglobulin kappa-Chains; Levetiracetam; Magnetic Resonance Imaging; Middle Aged; Multiple Myeloma; Neurologic Examination; Nimodipine; Nootropic Agents; Oligopeptides; Piracetam; Polyneuropathies; Posterior Leukoencephalopathy Syndrome; Secondary Prevention; Seizures

2016